Physician

Brian S Wojciechowski, MD

According to 2025 Medicare claims, Brian Wojciechowski, MD (NPI: 1730340639) practices hematology/oncology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Delaware, PA. This provider's primary affiliated billing organization is ALLIANCE CANCER SPECIALISTS P.C. (NPI: 1487923686; TIN: 452552343) and primary practice location at 19063-5105.

Wojciechowski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 659 traditional Medicare patients, billed 168,933 HCPCS/CPT codes, and received $2,576,209 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 715 prescription claims across 154 beneficiaries totaling $1,843,850 in drug costs, led by Lenalidomide (Lenalidomide). 2020 DME data shows 11 claims. Open Payments data shows 129 records totaling $2,977. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,624,019 and ending at $2,576,209. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $626,664 to $1,843,850. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.6M2015 Medicare payment: $1,624,019 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,549,942 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,422,216 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,828,082 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,649,152 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,261,663 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,202,901 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,219,217 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,809,213 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,576,209 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015530134,814$1,624,019
2016525126,299$1,549,942
2017499123,629$1,422,216
2018524134,326$1,828,082
2019502112,777$1,649,152
202051192,492$1,261,663
202152886,116$1,202,901
202253191,779$1,219,217
2023628111,900$1,809,213
2024659168,933$2,576,209

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.0M$2.0M2015 Drug cost: $626,664 (USD; Tot_Drug_Cst)2016 Drug cost: $922,155 (USD; Tot_Drug_Cst)2017 Drug cost: $698,841 (USD; Tot_Drug_Cst)2018 Drug cost: $1,229,902 (USD; Tot_Drug_Cst)2019 Drug cost: $1,997,642 (USD; Tot_Drug_Cst)2020 Drug cost: $1,897,286 (USD; Tot_Drug_Cst)2021 Drug cost: $1,473,849 (USD; Tot_Drug_Cst)2022 Drug cost: $2,038,023 (USD; Tot_Drug_Cst)2023 Drug cost: $1,275,491 (USD; Tot_Drug_Cst)2024 Drug cost: $1,843,850 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201599521$626,664
2016123682$922,155
2017130647$698,841
2018158847$1,229,902
2019144905$1,997,642
2020146835$1,897,286
2021137779$1,473,849
2022139757$2,038,023
2023145661$1,275,491
2024154715$1,843,850

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$10K$21K2015 Medicare payment: $6,943 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $20,836 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,142 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R95$6,943
2016N/R72$20,836
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R11$2,142
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more262419$101
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more272566$74
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's347560$14
36415Insertion of needle into vein for collection of blood sample3471,086$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count3351,059$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LenalidomideLenalidomide25665$342,364
PomalystPomalidomide13364$341,604
JakafiRuxolitinib Phosphate13364$213,144
VenclextaVenetoclax12360$187,649
EliquisApixaban923,175$60,481

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.129$2,977Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Brian S. Wojciechowski, MD?

Tedicare shows public-source Medicare data for Brian S. Wojciechowski, MD (NPI 1730340639), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian S. Wojciechowski, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Brian S. Wojciechowski, MD?

Brian S. Wojciechowski, MD is linked to ALLIANCE CANCER SPECIALISTS P.C. (billing NPI 1487923686) in the available physician profile data.

Does Brian S. Wojciechowski, MD have Open Payments data?

Brian S. Wojciechowski, MD has 129 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.